Results 201 to 210 of about 134,363 (333)
ESC Heart Failure, Volume 12, Issue 4, Page 2803-2813, August 2025.Abstract Aims Two general phenotypes of heart failure (HF) are recognized: HF with reduced ejection fraction (HFrEF) and with preserved EF (HFpEF). To develop phenotype‐specific approaches to treatment, distinguishing biomarkers are needed. The goal of this study was to utilize quantitative metabolomics on a large, diverse population to replicate and ...
Fawaz Naeem +13 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 4, Page 2834-2842, August 2025.The diagnostic pathway of high‐risk primary care patients through NT‐proBNP. Abstract Introduction Early detection of heart failure (HF), particularly in asymptomatic individuals, is essential for timely intervention. This study aimed to determine the prevalence of HF among high‐risk individuals in primary care using N‐terminal probrain natriuretic ...
Ahmet Celik +17 more
wiley +1 more source
Stratification of arrhythmic risk in patients eligible for crt: could the employment of bnp and twa be useful [PDF]
, 2005 M. Falcone +6 more
openalex +1 more source
ESC Heart Failure, Volume 12, Issue 4, Page 2843-2854, August 2025.Abstract Aims Right ventricular (RV) remodelling, a progressive condition characterized by maladaptive cardiac structural and functional changes, primarily results from prolonged pressure overload in patients with pulmonary hypertension (PH). Accurate, universal and easy‐to‐use biomarkers for assessing the severity of RV remodelling are lacking.
Xuenan Wang +5 more
wiley +1 more source
Prognostic value of the serum creatinine/albumin ratio for 28-day mortality in heart failure: a retrospective cohort study. [PDF]
Front Cardiovasc MedLuo H, Chen X.
europepmc +1 more source
NT-pro-BNP Identifies Patients with High Risk of Cardiac Events in the First Six Months after Cardiac Resynchronization Therapy [PDF]
, 2005 Giulia Ricciardi +9 more
openalex +1 more source
ESC Heart Failure, Volume 12, Issue 4, Page 3134-3144, August 2025.Abstract Background Sodium glucose co‐transporter 2 inhibitors (SGLT2i) and mineralocorticoid receptor antagonists (MRA) reduce heart failure (HF) events in patients with heart failure and mildly reduced or preserved ejection fraction (HFmr/pEF). The randomized comparison of SGLT2i/MRA combination versus SGLT2i or MRA alone requires further testing in ...
João Pedro Ferreira +26 more
wiley +1 more source
Natriuretic peptides as novel regulators of dendritic cells-mediated inflammation. [PDF]
Cell Mol Life SciManni G +9 more
europepmc +1 more source
Analytical Performance and Diagnostic Accuracy of Immunometric Assays for the Measurement of Plasma B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP [PDF]
, 2005 Aldo Clerico +7 more
openalex +1 more source